# Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair

> **NCT02128646** · PHASE4 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 19 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** EXPAREL
- **DRUG:** Ketorolac
- **PROCEDURE:** laparoscopic abdominal hernia repair
- **PROCEDURE:** an open surgery for abdominal hernia repair

## Key facts

- **NCT ID:** NCT02128646
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2025-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02128646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02128646, "Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02128646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*